Risk for Chronic Kidney Disease Progression After Acute Kidney Injury: Findings From the Chronic Renal Insufficiency Cohort Study
- PMID: 37429030
- PMCID: PMC10829039
- DOI: 10.7326/M22-3617
Risk for Chronic Kidney Disease Progression After Acute Kidney Injury: Findings From the Chronic Renal Insufficiency Cohort Study
Abstract
Background: Prior studies associating acute kidney injury (AKI) with more rapid subsequent loss of kidney function had methodological limitations, including inadequate control for differences between patients who had AKI and those who did not.
Objective: To determine whether AKI is independently associated with subsequent kidney function trajectory among patients with chronic kidney disease (CKD).
Design: Multicenter prospective cohort study.
Setting: United States.
Participants: Patients with CKD (n = 3150).
Measurements: Hospitalized AKI was defined by a 50% or greater increase in inpatient serum creatinine (SCr) level from nadir to peak. Kidney function trajectory was assessed using estimated glomerular filtration rate (eGFR) based on SCr level (eGFRcr) or cystatin C level (eGFRcys) measured at annual study visits.
Results: During a median follow-up of 3.9 years, 433 participants had at least 1 AKI episode. Most episodes (92%) had stage 1 or 2 severity. There were decreases in eGFRcr (-2.30 [95% CI, -3.70 to -0.86] mL/min/1.73 m2) and eGFRcys (-3.61 [CI, -6.39 to -0.82] mL/min/1.73 m2) after AKI. However, in fully adjusted models, the decreases were attenuated to -0.38 (CI, -1.35 to 0.59) mL/min/1.73 m2 for eGFRcr and -0.15 (CI, -2.16 to 1.86) mL/min/1.73 m2 for eGFRcys, and the CI bounds included the possibility of no effect. Estimates of changes in eGFR slope after AKI determined by either SCr level (0.04 [CI, -0.30 to 0.38] mL/min/1.73 m2 per year) or cystatin C level (-0.56 [CI, -1.28 to 0.17] mL/min/1.73 m2 per year) also had CI bounds that included the possibility of no effect.
Limitations: Few cases of severe AKI, no adjudication of AKI cause, and lack of information about nephrotoxic exposures after hospital discharge.
Conclusion: After pre-AKI eGFR, proteinuria, and other covariables were accounted for, the association between mild to moderate AKI and worsening subsequent kidney function in patients with CKD was small.
Primary funding source: National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.
Conflict of interest statement
Figures
Similar articles
-
The Association of Intraindividual Difference Between Cystatin- and Creatinine-Based Estimated GFR and Contrast-Associated Acute Kidney Injury.Clin Interv Aging. 2024 Mar 8;19:411-420. doi: 10.2147/CIA.S447042. eCollection 2024. Clin Interv Aging. 2024. PMID: 38476830 Free PMC article.
-
Association of Intraindividual Difference in Estimated Glomerular Filtration Rate by Creatinine vs Cystatin C and End-stage Kidney Disease and Mortality.JAMA Netw Open. 2022 Feb 1;5(2):e2148940. doi: 10.1001/jamanetworkopen.2021.48940. JAMA Netw Open. 2022. PMID: 35175342 Free PMC article.
-
Association of Intra-individual Differences in Estimated GFR by Creatinine Versus Cystatin C With Incident Heart Failure.Am J Kidney Dis. 2022 Dec;80(6):762-772.e1. doi: 10.1053/j.ajkd.2022.05.011. Epub 2022 Jul 9. Am J Kidney Dis. 2022. PMID: 35817274 Free PMC article.
-
Biomarkers During Recovery From AKI and Prediction of Long-term Reductions in Estimated GFR.Am J Kidney Dis. 2022 May;79(5):646-656.e1. doi: 10.1053/j.ajkd.2021.08.017. Epub 2021 Oct 12. Am J Kidney Dis. 2022. PMID: 34653541
-
Performance of the 2021 Race-Free CKD-EPI Creatinine- and Cystatin C-Based Estimated GFR Equations Among Kidney Transplant Recipients.Am J Kidney Dis. 2022 Oct;80(4):462-472.e1. doi: 10.1053/j.ajkd.2022.03.014. Epub 2022 May 16. Am J Kidney Dis. 2022. PMID: 35588905
Cited by
-
Plasma proteomics of acute tubular injury.Nat Commun. 2024 Aug 27;15(1):7368. doi: 10.1038/s41467-024-51304-x. Nat Commun. 2024. PMID: 39191768 Free PMC article.
-
Acute Kidney Injury and Its Association With Dementia and Specific Dementia Types: Findings From a Population-Based Study in Sweden.Neurology. 2024 Sep 24;103(6):e209751. doi: 10.1212/WNL.0000000000209751. Epub 2024 Aug 22. Neurology. 2024. PMID: 39173107 Free PMC article.
-
Therapeutic role of extracellular vesicles from human umbilical cord mesenchymal stem cells and their wide therapeutic implications in inflammatory bowel disease and other inflammatory disorder.Front Med (Lausanne). 2024 Jul 30;11:1406547. doi: 10.3389/fmed.2024.1406547. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39139783 Free PMC article. Review.
-
Clinical Characteristics and the Prognostic Impact of Acute Kidney Injury in Critically Ill Patients with Invasive Pulmonary Aspergillosis in the Intensive Care Unit: A Retrospective, Single-Center Study.Kidney Dis (Basel). 2024 May 7;10(4):262-273. doi: 10.1159/000539139. eCollection 2024 Aug. Kidney Dis (Basel). 2024. PMID: 39131885 Free PMC article.
-
Within and post-trial effects of an intensive lifestyle intervention on kidney disease in adults with overweight or obesity and type 2 diabetes mellitus: a secondary analysis of the Look AHEAD clinical trial.BMJ Open Diabetes Res Care. 2024 May 30;12(3):e004079. doi: 10.1136/bmjdrc-2024-004079. BMJ Open Diabetes Res Care. 2024. PMID: 38816203 Free PMC article. Clinical Trial.
References
-
- See EJ, Jayasinghe K, Glassford N, Bailey M, Johnson DW, Polkinghorne KR, et al. Long-term risk of adverse outcomes after acute kidney injury: a systematic review and meta-analysis of cohort studies using consensus definitions of exposure. Kidney International. 2019;95(1):160–72. - PubMed
-
- Weisbord SD, Gallagher M, Jneid H, Garcia S, Cass A, Thwin S-S, et al. Outcomes after angiography with sodium bicarbonate and acetylcysteine. New England Journal of Medicine. 2018;378(7):603–14. - PubMed
-
- Garg AX, Devereaux PJ, Yusuf S, Cuerden MS, Parikh CR, Coca SG, et al. Kidney function after off-pump or on-pump coronary artery bypass graft surgery: a randomized clinical trial. JAMA. 2014;311(21):2191–8. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- K23 DK119562/DK/NIDDK NIH HHS/United States
- U01 DK060963/DK/NIDDK NIH HHS/United States
- UL1 RR024131/RR/NCRR NIH HHS/United States
- U01 DK061022/DK/NIDDK NIH HHS/United States
- R01 DK119199/DK/NIDDK NIH HHS/United States
- UL1 TR000003/TR/NCATS NIH HHS/United States
- UL1 TR000439/TR/NCATS NIH HHS/United States
- R01 DK114014/DK/NIDDK NIH HHS/United States
- U01 DK060990/DK/NIDDK NIH HHS/United States
- K24 DK092291/DK/NIDDK NIH HHS/United States
- UL1 RR029879/RR/NCRR NIH HHS/United States
- U01 DK061028/DK/NIDDK NIH HHS/United States
- UL1 TR000433/TR/NCATS NIH HHS/United States
- U01 DK060984/DK/NIDDK NIH HHS/United States
- U01 DK061021/DK/NIDDK NIH HHS/United States
- U24 DK060990/DK/NIDDK NIH HHS/United States
- U01 DK060980/DK/NIDDK NIH HHS/United States
- UL1 TR000424/TR/NCATS NIH HHS/United States
- M01 RR016500/RR/NCRR NIH HHS/United States
- P20 GM109036/GM/NIGMS NIH HHS/United States
- U01 DK060902/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous